BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22916009)

  • 1. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.
    Peretz Y; He Z; Shi Y; Yassine-Diab B; Goulet JP; Bordi R; Filali-Mouhim A; Loubert JB; El-Far M; Dupuy FP; Boulassel MR; Tremblay C; Routy JP; Bernard N; Balderas R; Haddad EK; Sékaly RP
    PLoS Pathog; 2012; 8(8):e1002840. PubMed ID: 22916009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
    El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
    J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells.
    Zhang L; Zhang A; Xu J; Qiu C; Zhu L; Qiu C; Fu W; Wang Y; Ye L; Fu YX; Zhao C; Zhang X; Xu J
    Front Immunol; 2020; 11():2188. PubMed ID: 33072082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.
    Grabmeier-Pfistershammer K; Stecher C; Zettl M; Rosskopf S; Rieger A; Zlabinger GJ; Steinberger P
    Clin Immunol; 2017 Oct; 183():167-173. PubMed ID: 28882621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers.
    Pombo C; Wherry EJ; Gostick E; Price DA; Betts MR
    J Infect Dis; 2015 Nov; 212(9):1376-86. PubMed ID: 25883386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.
    Viganò S; Banga R; Bellanger F; Pellaton C; Farina A; Comte D; Harari A; Perreau M
    PLoS Pathog; 2014 Sep; 10(9):e1004380. PubMed ID: 25255144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD160 characterization and its association with disease progression in patients with chronic HIV-1 infection].
    Wang L; Xu X; Feng G; Zhang X; Wang F
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1559-62. PubMed ID: 25146744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection.
    Chibueze CE; Yoshimitsu M; Arima N
    Biochem Biophys Res Commun; 2014 Oct; 453(3):379-84. PubMed ID: 25277889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD160 Stimulates CD8
    Tan CL; Peluso MJ; Drijvers JM; Mera CM; Grande SM; Brown KE; Godec J; Freeman GJ; Sharpe AH
    Immunohorizons; 2018 Aug; 2(7):238-250. PubMed ID: 31022694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD160 expression on CD8
    Liu S; Zhang W; Liu K; Wang Y
    Cancer Immunol Immunother; 2020 May; 69(5):789-797. PubMed ID: 32055919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection.
    Del Rio ML; Nguyen TH; Tesson L; Heslan JM; Gutierrez-Adan A; Fernandez-Gonzalez R; Gutierrez-Arroyo J; Buhler L; Pérez-Simón JA; Anegon I; Rodriguez-Barbosa JI
    Transl Res; 2022 Jan; 239():103-123. PubMed ID: 34461306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.
    Yamamoto T; Price DA; Casazza JP; Ferrari G; Nason M; Chattopadhyay PK; Roederer M; Gostick E; Katsikis PD; Douek DC; Haubrich R; Petrovas C; Koup RA
    Blood; 2011 May; 117(18):4805-15. PubMed ID: 21398582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.
    Duraiswamy J; Ibegbu CC; Masopust D; Miller JD; Araki K; Doho GH; Tata P; Gupta S; Zilliox MJ; Nakaya HI; Pulendran B; Haining WN; Freeman GJ; Ahmed R
    J Immunol; 2011 Apr; 186(7):4200-12. PubMed ID: 21383243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
    Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
    Hoffmann M; Pantazis N; Martin GE; Hickling S; Hurst J; Meyerowitz J; Willberg CB; Robinson N; Brown H; Fisher M; Kinloch S; Babiker A; Weber J; Nwokolo N; Fox J; Fidler S; Phillips R; Frater J;
    PLoS Pathog; 2016 Jul; 12(7):e1005661. PubMed ID: 27415828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Trautmann L; Janbazian L; Chomont N; Said EA; Gimmig S; Bessette B; Boulassel MR; Delwart E; Sepulveda H; Balderas RS; Routy JP; Haddad EK; Sekaly RP
    Nat Med; 2006 Oct; 12(10):1198-202. PubMed ID: 16917489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin chemoresistance is associated with CD11b
    Anestakis D; Petanidis S; Domvri K; Tsavlis D; Zarogoulidis P; Katopodi T
    Mol Immunol; 2020 Feb; 118():99-109. PubMed ID: 31862674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.
    Bengsch B; Seigel B; Ruhl M; Timm J; Kuntz M; Blum HE; Pircher H; Thimme R
    PLoS Pathog; 2010 Jun; 6(6):e1000947. PubMed ID: 20548953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded antigen-experienced CD160
    Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.